MFDS
- Marketing authorisation holder: LILLY
- Status: likely_approved
🇰🇷 Metocurine in South Korea
Metocurine (dimethyltubocurarinium) regulatory status in South Korea.
Marketing authorisation
Metocurine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Metocurine approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Metocurine in South Korea?
LILLY holds the South Korean marketing authorisation.